Advertisement Life Technologies to supply Dynabeads to Epigenomics - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Life Technologies to supply Dynabeads to Epigenomics

Life Technologies will supply its Dynabeads MyOne SILANE and buffer to Epigenomics for its Epi proColon 2.0, a second-generation colorectal cancer blood test.

The test is said to be in development for the European and US in vitro diagnostic (IVD) market.

Dynabeads MyOne SILANE are monosized, magnetic beads that bind to nucleic acids (NAs) in biological samples.

Epi proColon 2.0 requires fewer components and handling steps and can reach results within 8 hours which makes it to automate on IVD automation solutions, as compared to the first generation test system.

Epigenomics is likely to conduct analytical and clinical validation studies in the second half of 2011.